ANTI-MUCI ANTIBODY

CY1126182T1Undetermined Publication Date: 2026-07-31GLYCOTOPE GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CY20231100365T
Authority / Receiving Office
CY · CY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-05-18
Filing Date
2023-07-26
Publication Date
2026-07-31
Estimated Expiration
2043-07-26
Patent Text Reader

Abstract

The present disclosure relates to antibody-drug conjugates directed against the cancer antigen MUC1. In particular, an antibody with improved antigen binding was obtained by deleting a glycosylation site in the CDR-H2 of a known anti-MUC 1 antibody. The conjugates consist of hexathecan derivatives conjugated to the anti-MUC1 antibodies.
Need to check novelty before this filing date? Find Prior Art